Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secukinumab-induced subacute cutaneous lupus erythematosus.
Conforti C, Retrosi C, Giuffrida R, Vezzoni R, Currado D, Navarini L, Farinazzo E, Dell'Aquila C, Nan K, Di Meo N, Zalaudek I. Conforti C, et al. Dermatol Ther. 2020 May;33(3):e13417. doi: 10.1111/dth.13417. Epub 2020 May 3. Dermatol Ther. 2020. PMID: 32291870 Free article. No abstract available.
Inverse psoriasis in patient treated with atezolizumab.
Corneli P, di Meo N, Fagotti S, Conforti C, Farinazzo E, Zacchi A, Retrosi C, Vezzoni R, Pizzichetta MA, Zalaudek I. Corneli P, et al. Among authors: conforti c. Int J Dermatol. 2020 Sep;59(9):e331-e332. doi: 10.1111/ijd.14876. Epub 2020 Apr 28. Int J Dermatol. 2020. PMID: 32346858 Free article. No abstract available.
Moderate-to-severe plaque psoriasis, described by PASI ≥10%, can be associated with higher cardiovascular risk according to seven risk algorithms: Results of a 10-year single-center retrospective study and clinical management of psoriatic patients with cardiovascular risk.
Conforti C, Currado D, Navarini L, Retrosi C, Giuffrida R, Zelin E, Afeltra A, di Meo N, Dianzani C, Zalaudek I. Conforti C, et al. Dermatol Ther. 2020 Nov;33(6):e14451. doi: 10.1111/dth.14451. Epub 2020 Nov 14. Dermatol Ther. 2020. PMID: 33098612 No abstract available.
Necrobiosis-Lipoidica-Like Skin Lesions in a Patient with Non-Systemic Sarcoidosis.
Bearzi P, Trunfio F, Coppola R, Currado D, Conforti C, Zanframundo S, Nibid L, Donati M, Panasiti V, Navarini L, Giacomelli R. Bearzi P, et al. Among authors: conforti c. Dermatol Pract Concept. 2023 Jul 1;13(3):e2023183. doi: 10.5826/dpc.1303a183. Dermatol Pract Concept. 2023. PMID: 37557149 Free PMC article. No abstract available.
Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.
Zalaudek I, Corneli P, Vernoni S, Fedele D, Papa G, Conforti C, Retrosi C, Vezzoni R, Fagotti S, Longone M, Farinazzo E, di Meo N, Pizzichetta MA. Zalaudek I, et al. Among authors: conforti c. Dermatol Ther. 2019 Nov;32(6):e13107. doi: 10.1111/dth.13107. Epub 2019 Oct 21. Dermatol Ther. 2019. PMID: 31595596 No abstract available.
Benign dermatoses of the male genital areas: A review of the literature.
Conforti C, Giuffrida R, Di Meo N, Longone M, Vichi S, Colli C, Deinlein T, Vezzoni R, Retrosi C, Errichetti E, Cannavò SP, Zalaudek I, Dianzani C. Conforti C, et al. Dermatol Ther. 2020 May;33(3):e13355. doi: 10.1111/dth.13355. Epub 2020 May 5. Dermatol Ther. 2020. PMID: 32239734 Free article. Review.
What makes an inflammatory disease inflammatory? An overview of inflammatory mechanisms of allergic contact dermatitis, atopic dermatitis and psoriasis.
Farinazzo E, Giuffrida R, Dianzani C, Vezzoni R, Retrosi C, Zalaudek I, Conforti C. Farinazzo E, et al. Among authors: conforti c. G Ital Dermatol Venereol. 2020 Dec;155(6):719-723. doi: 10.23736/S0392-0488.20.06551-7. Epub 2020 Apr 29. G Ital Dermatol Venereol. 2020. PMID: 32348082 Free article. Review.
190 results